Vectibix IV infusion 100mg, manufactured by Takeda Pharmaceutical, contains Panitumumab (genetical recombination). With YJ code 4291417A1020 and standard 100mg 5mL 1 bottle, it is a monoclonal antibody used for the treatment of certain types of metastatic colorectal cancer.
Vectibix IV infusion 100mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →